104 related articles for article (PubMed ID: 8543936)
1. Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis.
Orrell RW; King AW; Lane RJ; de Belleroche JS
J Neurol Sci; 1995 Oct; 132(2):126-8. PubMed ID: 8543936
[TBL] [Abstract][Full Text] [Related]
2. [Deficiency of human ciliary neurotropic factor (CNTF) is not causally related to amyotrophic lateral sclerosis (ALS)].
Takahashi R
Rinsho Shinkeigaku; 1995 Dec; 35(12):1543-5. PubMed ID: 8752458
[TBL] [Abstract][Full Text] [Related]
3. Ciliary neurotrophic factor (CNTF) genotypes and CNTF contents in human sciatic nerves as measured by a sensitive enzyme-linked immunoassay.
Takahashi R; Kawamura K; Hu J; Hayashi M; Deguchi T
J Neurochem; 1996 Aug; 67(2):525-9. PubMed ID: 8764576
[TBL] [Abstract][Full Text] [Related]
4. Potential implications of a ciliary neurotrophic factor gene mutation in a German population of patients with motor neuron disease.
Giess R; Goetz R; Schrank B; Ochs G; Sendtner M; Toyka K
Muscle Nerve; 1998 Feb; 21(2):236-8. PubMed ID: 9466600
[TBL] [Abstract][Full Text] [Related]
5. Homozygotes and heterozygotes for ciliary neurotrophic factor null alleles do not show earlier onset of Huntington's disease.
Rubinsztein DC; Leggo J; Chiano M; Korn S; Dodge A; Norbury G; Rosser E; Craufurd D
Neurology; 1997 Sep; 49(3):890-2. PubMed ID: 9305364
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in the ciliary neurotrophic factor receptor alpha gene and familial amyotrophic lateral sclerosis.
Imura T; Shimohama S; Kawamata J; Kimura J
Ann Neurol; 1998 Feb; 43(2):275. PubMed ID: 9485075
[No Abstract] [Full Text] [Related]
7. Decrease in the ciliary neurotrophic factor of the spinal cord in amyotrophic lateral sclerosis.
Ono S; Imai T; Igarashi A; Shimizu N; Nakagawa H; Hu J
Eur Neurol; 1999; 42(3):163-8. PubMed ID: 10529543
[TBL] [Abstract][Full Text] [Related]
8. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
Al-Chalabi A; Scheffler MD; Smith BN; Parton MJ; Cudkowicz ME; Andersen PM; Hayden DL; Hansen VK; Turner MR; Shaw CE; Leigh PN; Brown RH
Ann Neurol; 2003 Jul; 54(1):130-4. PubMed ID: 12838531
[TBL] [Abstract][Full Text] [Related]
9. A null mutation allele in the CNTF gene and schizophrenic psychoses.
Thome J; Durany N; Harsányi A; Foley P; Palomo A; Kornhuber J; Weijers HG; Baumer A; Rösler M; Cruz-Sánchez FF; Beckmann H; Riederer P
Neuroreport; 1996 May; 7(8):1413-6. PubMed ID: 8856688
[TBL] [Abstract][Full Text] [Related]
10. Ciliary neurotrophic factor null alleles are not a risk factor for Charcot-Marie-Tooth disease, hereditary neuropathy with pressure palsies and amyotrophic lateral sclerosis.
Van Vught PW; Van Wijk J; Bradley TE; Plasmans D; Jakobs ME; Veldink JH; de Jong JM; Van den Berg LH; Baas F
Neuromuscul Disord; 2007 Dec; 17(11-12):964-7. PubMed ID: 17651970
[TBL] [Abstract][Full Text] [Related]
11. Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease.
Anand P; Parrett A; Martin J; Zeman S; Foley P; Swash M; Leigh PN; Cedarbaum JM; Lindsay RM; Williams-Chestnut RE
Nat Med; 1995 Feb; 1(2):168-72. PubMed ID: 7585015
[TBL] [Abstract][Full Text] [Related]
12. Expression of ciliary neurotrophic factor is maintained in spinal motor neurons of amyotrophic lateral sclerosis.
Schorr M; Zhou L; Schwechheimer K
J Neurol Sci; 1996 Sep; 140(1-2):117-22. PubMed ID: 8866436
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenic psychoses and the CNTF null mutation.
Tanaka Y; Ujike H; Fujiwara Y; Takeda T; Takehisa Y; Kodama M; Otsuki S; Kuroda S
Neuroreport; 1998 Apr; 9(6):981-3. PubMed ID: 9601653
[TBL] [Abstract][Full Text] [Related]
14. Ciliary neurotrophic factor receptor expression in spinal cord and motor cortex in amyotrophic lateral sclerosis.
Duberley RM; Johnson IP; Anand P; Swash M; Martin J; Leigh PN; Zeman S
J Neurol Sci; 1995 May; 129 Suppl():109-13. PubMed ID: 7595599
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients.
Aebischer P; Schluep M; Déglon N; Joseph JM; Hirt L; Heyd B; Goddard M; Hammang JP; Zurn AD; Kato AC; Regli F; Baetge EE
Nat Med; 1996 Jun; 2(6):696-9. PubMed ID: 8640564
[TBL] [Abstract][Full Text] [Related]
16. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Eur Cytokine Netw; 2003; 14(3):192-4. PubMed ID: 14656696
[TBL] [Abstract][Full Text] [Related]
17. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group.
Neurology; 1996 May; 46(5):1244-9. PubMed ID: 8628460
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic benefit of ciliary neurotrophic factor in progressive motor neuronopathy depends on the route of delivery.
Haase G; Pettmann B; Bordet T; Villa P; Vigne E; Schmalbruch H; Kahn A
Ann Neurol; 1999 Mar; 45(3):296-304. PubMed ID: 10072043
[TBL] [Abstract][Full Text] [Related]
19. A null mutation in the human CNTF gene is not causally related to neurological diseases.
Takahashi R; Yokoji H; Misawa H; Hayashi M; Hu J; Deguchi T
Nat Genet; 1994 May; 7(1):79-84. PubMed ID: 8075647
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial).
Penn RD; Kroin JS; York MM; Cedarbaum JM
Neurosurgery; 1997 Jan; 40(1):94-9; discussion 99-100. PubMed ID: 8971830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
